Loading
PP
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) Stock: price and insider trades · Canada
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.): what insiders have been doing
This page follows insider dealings at Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) as filed with SEDI. Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) has had no insider filing for more than a year; the last one goes back to 17 November 2023.
Our records for Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) go back to 2017, with 6 purchases and no sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€88,800
6 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 17 November 2023
Declarations29 total
8,500 shares@ CA$0.7661.2% of flowCommon SharesTSXSEDI:3167940
Canonical exit: 27 Jun 2018 (T+90)
25,000 sharesCommon SharesTSXSEDI:3257220
1,200,000 sharesCommon SharesTSXSEDI:3257219
375,000 shares@ CA$0.40100.0% of flowCommon SharesTSXSEDI:3256084
Common SharesTSXSEDI:3256085
29,763 sharesCommon SharesTSXSEDI:3256044
61,647 sharesCommon SharesTSXSEDI:3256045
750,000 sharesCommon SharesTSXSEDI:3256043
Common SharesTSXSEDI:3256041
136,500 shares@ CA$0.5614.7% of flowCommon SharesTSXSEDI:3185746
Canonical exit: 13 Aug 2018 (T+90)
400 shares@ CA$0.87100.0% of flowCommon SharesTSXSEDI:3172769
Canonical exit: 9 Jul 2018 (T+90)
55,000 shares@ CA$0.9910.0% of flowCommon SharesTSXSEDI:3167939
Canonical exit: 1 Jul 2018 (T+90)
20,000 sharesCommon SharesTSXSEDI:3142828
Canonical exit: 27 May 2018 (T+90)
42,000 sharesCommon SharesTSXSEDI:3142829
Canonical exit: 27 May 2018 (T+90)
2,747,252 sharesCommon SharesTSXSEDI:3140909
300,000 shares@ CA$0.8046.1% of flowCommon SharesTSXSEDI:3121597
165,125,212 sharesCommon SharesTSXSEDI:3098988
1,800,000 sharesCommon SharesTSXSEDI:3098978
Common SharesTSXSEDI:3098964
1,800,000 sharesCommon SharesTSXSEDI:3098979
Common SharesTSXSEDI:3098997
47,649,500 sharesCommon SharesTSXSEDI:3098999
182,675,711 sharesCommon SharesTSXSEDI:3098993
100,000 sharesCommon SharesTSXSEDI:3098967
Common SharesTSXSEDI:3098629
25 of 29 declarations
About Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Pivot Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative treatments for various medical conditions. Formerly known as Neurokine Pharmaceuticals Inc., it is listed on the XTSE.
